Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
13 01 2021
Historique:
received: 07 05 2020
accepted: 25 10 2020
pubmed: 6 11 2020
medline: 16 3 2021
entrez: 5 11 2020
Statut: epublish

Résumé

Given the projected increase in multidrug-resistant HIV-1, there is an urgent need for development of antiretrovirals that act on virus life cycle stages not targeted by drugs currently in use. Host-targeting compounds are of particular interest because they can offer a high barrier to resistance. Here, we report identification of two related small molecules that inhibit HIV-1 late events, a part of the HIV-1 life cycle for which potent and specific inhibitors are lacking. This chemotype was discovered using cell-free protein synthesis and assembly systems that recapitulate intracellular host-catalyzed viral capsid assembly pathways. These compounds inhibit replication of HIV-1 in human T cell lines and peripheral blood mononuclear cells, and are effective against a primary isolate. They reduce virus production, likely by inhibiting a posttranslational step in HIV-1 Gag assembly. Notably, the compound colocalizes with HIV-1 Gag

Identifiants

pubmed: 33148797
pii: JVI.00883-20
doi: 10.1128/JVI.00883-20
pmc: PMC7925099
pii:
doi:

Substances chimiques

ABCE1 protein, human 0
ATP-Binding Cassette Transporters 0
Anti-Retroviral Agents 0
Proto-Oncogene Proteins 0
Small Molecule Libraries 0
gag Gene Products, Human Immunodeficiency Virus 0
DDX6 protein, human EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI150457
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI154963
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI145498
Pays : United States

Informations de copyright

Copyright © 2021 Reed et al.

Références

J Med Chem. 2016 Jan 28;59(2):545-58
pubmed: 26685880
AIDS. 2014 Jan;28 Suppl 1:S15-23
pubmed: 24468943
Nature. 2002 Jan 3;415(6867):88-92
pubmed: 11780123
Proc Natl Acad Sci U S A. 1974 Sep;71(9):3435-9
pubmed: 4530315
J Nat Prod. 1994 Feb;57(2):243-7
pubmed: 8176401
J Virol. 1992 Nov;66(11):6547-54
pubmed: 1404602
Antimicrob Agents Chemother. 1996 Feb;40(2):292-7
pubmed: 8834868
J Virol. 2010 Oct;84(19):10241-53
pubmed: 20668078
J Virol. 2004 Sep;78(17):9560-3
pubmed: 15308748
RNA. 2019 Jun;25(6):727-736
pubmed: 30902835
J Virol. 2009 May;83(10):4844-53
pubmed: 19279116
J Virol. 2004 Sep;78(17):9257-69
pubmed: 15308720
Nat Methods. 2006 Dec;3(12):995-1000
pubmed: 17072308
PLoS Pathog. 2018 Apr 17;14(4):e1006977
pubmed: 29664940
BMC Bioinformatics. 2015;16 Suppl 19:S10
pubmed: 26695135
Viruses. 2018 Nov 15;10(11):
pubmed: 30445742
J Virol Methods. 2005 Jun;126(1-2):13-20
pubmed: 15847914
Clin Infect Dis. 2015 Nov 1;61(9):1453-61
pubmed: 26157050
Biochemistry. 2018 May 1;57(17):2424-2431
pubmed: 29381060
J Biol Chem. 2010 Dec 10;285(50):39314-28
pubmed: 20937817
Curr Opin HIV AIDS. 2018 Jul;13(4):359-365
pubmed: 29782334
Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905
pubmed: 12019106
J Biol Chem. 2009 Sep 25;284(39):26941-50
pubmed: 19617355
Infect Dis Clin North Am. 2019 Sep;33(3):787-805
pubmed: 31395145
J Virol. 2015 Sep;89(17):9068-79
pubmed: 26109731
Nat Struct Mol Biol. 2005 Aug;12(8):671-7
pubmed: 16041387
PLoS Genet. 2015 Sep 30;11(9):e1005528
pubmed: 26421679
RNA. 2006 Jan;12(1):94-101
pubmed: 16373495
J Cell Biol. 1997 Feb 10;136(3):567-81
pubmed: 9024688
Curr Opin HIV AIDS. 2009 Sep;4(5):408-17
pubmed: 20048705
PLoS Pathog. 2011 Oct;7(10):e1002303
pubmed: 22022269
J Virol. 1995 Feb;69(2):882-8
pubmed: 7815556
Lancet Infect Dis. 2017 Mar;17(3):296-304
pubmed: 27914856
J Virol. 2015 Jan 15;89(2):894-907
pubmed: 25378497
J Virol. 1998 Apr;72(4):2855-64
pubmed: 9525605
J Virol. 2008 Dec;82(24):12585-8
pubmed: 18842727
PLoS Pathog. 2010 Dec 09;6(12):e1001220
pubmed: 21170360
J Biol Chem. 2006 Feb 17;281(7):3773-84
pubmed: 16275648
J Virol. 2012 Jun;86(12):6643-55
pubmed: 22496222
J Virol. 2011 Oct;85(20):10785-97
pubmed: 21835789
Adv Exp Med Biol. 2013;768:197-211
pubmed: 23224972
J Virol. 2009 Sep;83(17):9002-7
pubmed: 19535443
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5215-20
pubmed: 10220446
Retrovirology. 2008 May 22;5:41
pubmed: 18498651
Antiviral Res. 2009 Apr;82(1):67-72
pubmed: 19428597
Drugs. 2005;65(15):2209-44
pubmed: 16225378
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50
pubmed: 10430945
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Curr HIV Res. 2016;14(3):270-82
pubmed: 26957201
J Cell Sci. 2010 Feb 1;123(Pt 3):369-83
pubmed: 20053637
J Virol. 1986 Aug;59(2):284-91
pubmed: 3016298
J Virol. 2011 Jul;85(14):7419-35
pubmed: 21543480
Biochem J. 2017 Apr 26;474(10):1559-1577
pubmed: 28446620
Viruses. 2009 Dec;1(3):1110-36
pubmed: 21994585
J Virol. 2005 May;79(10):5996-6004
pubmed: 15857986
J Biol Chem. 2002 Feb 22;277(8):5952-61
pubmed: 11741936
J Virol. 2019 Mar 5;93(6):
pubmed: 30567984
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2195-208
pubmed: 26810656
J Virol. 2015 Dec 09;90(4):1944-63
pubmed: 26656702
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18625-30
pubmed: 25518861
Nat Med. 2019 Sep;25(9):1377-1384
pubmed: 31501601
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E861-8
pubmed: 23404707
J Mol Biol. 2011 Jul 22;410(4):756-60
pubmed: 21762813
J Virol. 2005 Jun;79(11):6814-26
pubmed: 15890921
Curr Opin Virol. 2012 Oct;2(5):656-62
pubmed: 22989757
J Virol. 1999 Jul;73(7):5255-64
pubmed: 10364271
J Virol. 2001 Jun;75(12):5473-81
pubmed: 11356954
Cell Host Microbe. 2019 Jul 10;26(1):48-60
pubmed: 31295424
J Cell Biol. 2012 Aug 6;198(3):439-56
pubmed: 22851315
J Virol. 2007 Jun;81(12):6216-30
pubmed: 17428849
AIDS Res Hum Retroviruses. 2009 Aug;25(8):811-7
pubmed: 19619009
PLoS One. 2010 Feb 05;5(2):e9081
pubmed: 20140200
Med Res Rev. 2020 Sep;40(5):1519-1557
pubmed: 32060956
Virology. 2001 Jan 5;279(1):257-70
pubmed: 11145907
J Biol Chem. 1988 Apr 25;263(12):5870-5
pubmed: 3258602
Lancet Infect Dis. 2017 Mar;17(3):241-243
pubmed: 27914855
PLoS One. 2019 Oct 17;14(10):e0224076
pubmed: 31622432
J Virol. 2006 Jan;80(2):835-44
pubmed: 16378985
J Cell Biol. 2005 Jun 20;169(6):871-84
pubmed: 15967811
J Virol. 2011 Jan;85(1):542-9
pubmed: 20962083
J Virol. 2005 Jan;79(2):764-70
pubmed: 15613304
J Virol. 2018 Sep 26;92(20):
pubmed: 30089694
Genome Res. 2005 May;15(5):641-54
pubmed: 15837808
J Virol. 2012 Feb;86(4):2312-22
pubmed: 22171279
J Virol. 2018 Apr 13;92(9):
pubmed: 29467316
PLoS One. 2012;7(12):e50859
pubmed: 23227216
J Antimicrob Chemother. 2005 Jun;55(6):817-20
pubmed: 15845781
Drugs Context. 2018 Feb 21;7:212522
pubmed: 29497452
ACS Chem Biol. 2015 Aug 21;10(8):1785-90
pubmed: 25997366
Nucleic Acids Res. 2003 Jan 1;31(1):298-303
pubmed: 12520007
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17355-60
pubmed: 17065321
Antimicrob Agents Chemother. 2013 Aug;57(8):4035-8
pubmed: 23689710
J Virol. 2009 Aug;83(16):8289-92
pubmed: 19474095
J Virol. 2010 Nov;84(22):11961-9
pubmed: 20810732
Traffic. 2007 Mar;8(3):195-211
pubmed: 17233757
J Virol. 2011 Apr;85(8):3940-9
pubmed: 21289114
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60
pubmed: 14573704
J Virol. 2014 May;88(10):5718-41
pubmed: 24623418
J Virol. 2000 Sep;74(18):8358-67
pubmed: 10954535
Virology. 2005 Mar 1;333(1):114-23
pubmed: 15708597
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9040-9049
pubmed: 30975760
J Virol. 2004 Feb;78(4):1645-56
pubmed: 14747530
Science. 1985 Aug 9;229(4713):563-6
pubmed: 2992081
J Biol Chem. 2006 Jan 13;281(2):1241-50
pubmed: 16275650
Antimicrob Agents Chemother. 2008 Apr;52(4):1302-17
pubmed: 18212100

Auteurs

Jonathan C Reed (JC)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Dennis Solas (D)

Prosetta Biosciences, San Francisco, California, USA.

Anatoliy Kitaygorodskyy (A)

Prosetta Biosciences, San Francisco, California, USA.

Beverly Freeman (B)

Prosetta Biosciences, San Francisco, California, USA.

Dylan T B Ressler (DTB)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Daryl J Phuong (DJ)

Department of Global Health, University of Washington, Seattle, Washington, USA.

J Victor Swain (JV)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Kent Matlack (K)

Prosetta Biosciences, San Francisco, California, USA.

Clarence R Hurt (CR)

Prosetta Biosciences, San Francisco, California, USA.

Vishwanath R Lingappa (VR)

Prosetta Biosciences, San Francisco, California, USA.

Jaisri R Lingappa (JR)

Department of Global Health, University of Washington, Seattle, Washington, USA jais@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH